Combination of human anti-FGFR4 antibody and Sorafenib
US-10995143-B2 · May 4, 2021 · US
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 55435971 |
| Family type | — |
| Earliest priority | Feb 10, 2016 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US10995143B2 — Combination of human anti-FGFR4 antibody and Sorafenib |
Best representative member for this family based on priority and filing country.
US10995143B2 — Combination of human anti-FGFR4 antibody and Sorafenib (published May 4, 2021)
Related publications in this family.
US-10995143-B2 · May 4, 2021 · US
US-2019048088-A1 · Feb 14, 2019 · US